Helicobacter pylori eradication: Sequential therapy and Lactobacillus reuteri supplementation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 43

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

431

HTML

3293

Figures (1-1)

174

Tables (1-1)

114

Sum=4012

Nov 21, 2012 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 21, 2012; 18(43): 6250-6254
Published online Nov 21, 2012. doi: 10.3748/wjg.v18.i43.6250

Table 1 Demographic characteristics of the patient groups

Therapy	Patients	Mean age (yr)	Male/female
7-d standard triple therapy plus L. reuteri during therapy	11	54 ± 8	6/5
7-d standard triple therapy plus L. reuteri post therapy	8	59 ± 5	2/6
10-d sequential therapy plus L. reuteri during therapy	32	57 ± 2	7/25
10-d sequential therapy plus L. reuteri post therapy	32	60 ± 2	11/21

L. reuteri:Lactobacillus reuteri.

Citation: Efrati C, Nicolini G, Cannaviello C, O’Sed NP, Valabrega S. Helicobacter pylori eradication: Sequential therapy and Lactobacillus reuteri supplementation. World J Gastroenterol 2012; 18(43): 6250-6254
URL: https://www.wjgnet.com/1007-9327/full/v18/i43/6250.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i43.6250